All In MedTech

FDA Clearance Tracker · P010030-S067

HOSPITAL WEARABLE DEFIBRILLATOR (HWD 1000)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 24, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 24, 2017

Approved

Time to decision

511 days

Received Oct 2, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P010030-S067
Device name
HOSPITAL WEARABLE DEFIBRILLATOR (HWD 1000)
Applicant location
Pittsburgh, PA
Received
Oct 2, 2015
Decided
Feb 24, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P010030

Device type

Device class
Class III

Every decision under product code MVK

FDA's approval statement

As written in FDA's record.

Approval for the HWD 1000 System. This is a wearable defibrillation for hospital use that is based on the previously approved LifeVest Wearable Cardioverter Defibrillator (WCD) 4000 design as a platform and incorporates design features from the previously approved WCD 3000S.

Source documents

Other decisions for Zoll Manufacturing Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.